A pharmaceutical company claims that the variability in the effectiveness of its new drug is less than that of a competitor's drug. A sample of $15$ patients using the new drug has a variance of $1.2$, while a sample of $20$ patients using the competitor's drug has a variance of $2.8$. At $\alpha =0.01$, is there enough evidence to support the company's claim?